Disruption of Cholesterol Efflux by Coxib Medications and Inflammatory Processes: Link to Increased Cardiovascular Risk

Atherosclerosis is a chronic progressive disease that is a major contributor to cardiac death. It is characterized by inflammation and cholesterol deposition in the arterial wall. Excess cholesterol accumulation occurs as a result of an imbalance between delivery and removal and leads to formation o...

Full description

Saved in:
Bibliographic Details
Published in:Journal of investigative medicine 2009-08, Vol.57 (6), p.695-702
Main Authors: Reiss, Allison B., Anwar, Farah, Chan, Edwin S.L., Anwar, Kamran
Format: Article
Language:English
Subjects:
Atherosclerosis - etiology
Atherosclerosis - metabolism
Atherosclerosis - pathology
ATP Binding Cassette Transporter 1
ATP-Binding Cassette Transporters - metabolism
Biological Transport - drug effects
Cholesterol - metabolism
Cholesterol 7-alpha-Hydroxylase - metabolism
Cyclooxygenase 2 Inhibitors - pharmacology
Humans
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Atherosclerosis is a chronic progressive disease that is a major contributor to cardiac death. It is characterized by inflammation and cholesterol deposition in the arterial wall. Excess cholesterol accumulation occurs as a result of an imbalance between delivery and removal and leads to formation of lipid-laden foam cells. Removal of cholesterol through a process known as reverse cholesterol transport requires the coordinated functioning of a number of genes including the P450 27-hydroxylase and the adenosine triphosphate-binding cassette transporter A1 (ABCA1). Reverse cholesterol transport is a key defense against atheroma formation. This review discusses the role of inflammatory processes in impeding reverse cholesterol transport. Particular emphasis is placed on the disruption of cholesterol outflow observed in the presence of cyclooxygenase inhibitors in cultured monocytes/macrophages. These inhibitors, which are used clinically to relieve pain and inflammation, have been associated with increased risk of cardiovascular disease and myocardial infarction. We explore the relationship between suppression of reverse cholesterol transport and harmful cardiac effects of coxibs.
ISSN:1081-5589
1708-8267
DOI:10.2310/JIM.0b013e31819ec3c7